Clinical Trials on Chronic Obstructive Airway Disease in United Kingdom

Total 15533 results

University of Leeds
The Leeds Teaching Hospitals NHS Trust

Recruiting

Evaluating Treatable Traits Across the Spectrum of Chronic Obstructive Airways Disease

Airway Disease

United Kingdom
Northumbria Healthcare NHS Foundation Trust
Newcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research... and other collaborators

Completed

Mortality and Symptom Burden Post Hospitalisation With COPD (MoSHCOPD)

Pulmonary Disease, Chronic Obstructive | Emphysema | Chronic Bronchitis | Pulmonary Disease, Obstructive | Chronic Bronchitis With Airways Obstruction | Chronic Bronchitis With Acute Exacerbation

United Kingdom
Imperial College London
Asthma UK

Withdrawn

Regulation of the Release of Inflammatory Mediators From Blood Leukocytes

Healthy Volunteers | Chronic Obstructive Airway Disease

United Kingdom
Hywel Dda Health Board

Completed

Exercise and Neutrophil Function in COPD

Chronic Obstructive Airway Disease | Neutrophil Function Disorder

United Kingdom
Manchester University NHS Foundation Trust

Completed

Cough Responses to Tussive Agents in Health and Disease

Asthma | Chronic Cough | Chronic Obstructive Airway Disease

United Kingdom
Temple University
National Center for Complementary and Integrative Health (NCCIH); Quercegen...

Recruiting

Biological Effects of Quercetin in COPD Phase II (polyphenols)

Chronic Obstructive Pulmonary Disease | Emphysema | Chronic Bronchitis With Airway Obstruction

United States
Breathe Technologies, Inc.

Completed

Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) (PRIDE)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease | Airflow Obstruction, Chronic

United States
Breathe Technologies, Inc.

Completed

In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease | Airflow Obstruction, Chronic

United States
AstraZeneca

Completed

AZD2115 Single Ascending Dose Study

Chronic Obstructive Pulmonary Disease | Lung Disease Causing Persistent Narrowing of the Airways

United Kingdom
Aerocrine AB

Completed

Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Imperial College London

Unknown

Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19 (PASSPORT)

COVID-19 | Asthma | Copd | Small Airways Disease

United Kingdom
Icahn School of Medicine at Mount Sinai
University of Pittsburgh; Brigham and Women's Hospital; University of New Mexico and other collaborators

Active, not recruiting

WTC Chest CT Imaging Archive

Lung Cancer | Interstitial Lung Disease | Chronic Airway Disease

United States
Brigham and Women's Hospital
Massachusetts General Hospital

Withdrawn

Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)

Chronic Obstructive Airway Disease

United States
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Imperial College Healthcare NHS Trust
National Institute for Health Research, United Kingdom

Terminated

The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients

Chronic Obstructive Pulmonary Diseases

United Kingdom
Guy's and St Thomas' NHS Foundation Trust
University of Cambridge; Pneumacare Ltd

Completed

Structured Light Plethysmography in Obstructive Airways Disease

Pediatric Respiratory Diseases

United Kingdom
King's College Hospital NHS Trust
University of Brighton

Completed

The Effects of a Home Exercise Video Programme for Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
my mhealth Ltd
Portsmouth Hospitals NHS Trust

Completed

Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD (RESCUE)

Chronic Obstructive Pulmonary Diseases

United Kingdom
University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
my mhealth Ltd
Portsmouth Hospitals NHS Trust

Completed

Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD (TROOPeR)

Chronic Obstructive Pulmonary Diseases

United Kingdom
AstraZeneca

Terminated

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease (TREAT)

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

United Kingdom
The Royal Wolverhampton Hospitals NHS Trust

Withdrawn

Cricothyroidotomy Training for Physicians Outcomes Study

Airway Obstruction

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Suspended

Efficacy of an Advanced Auto-titrating NIV in COPD

Chronic Obstructive Pulmonary Disease Severe

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD) | COPD

United Kingdom
Pulmatrix Inc.
Quotient Clinical

Completed

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
Pulmatrix Inc.

Completed

A Phase 1b Study of PUR1800 in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Asger Sverrild
AstraZeneca; University Hospitals, Leicester; University Hospital, Antwerp

Recruiting

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD (UPSTREAM-COPD)

COPD | COPD Exacerbation | Immune System Disorder | Airway Disease | COPD Bronchitis

United Kingdom, Belgium, Denmark
AstraZeneca
Parexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

Chronic Obstructive Pulmonary Disease - COPD

United Kingdom
Respivert Ltd

Completed

Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients

Healthy Volunteers | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London

Completed

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Verona Pharma plc

Completed

The Effects of RPL554 on Top of Standard COPD Reliever Medications

Chronic Obstructive Pulmonary Disease

United Kingdom
Pulmatrix Inc.
Quotient Bioresearch

Completed

Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118

Chronic Obstructive Pulmonary Disease

United Kingdom
NHS Greater Glasgow and Clyde
Chief Scientist Office of the Scottish Government

Unknown

Glasgow Supported Self Management Trial (GSuST) (GSuST)

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London
University of Nottingham; University College, London; University of Southampton; Queen's University, Belfast and other collaborators

Active, not recruiting

The BLF Early COPD Development Partnership Grant

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Dundee
Tenovus Scotland

Completed

Beta Blocker Therapy in Moderate to Severe COPD (ANDA2)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca
Quintiles, Inc.

Completed

This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral Dose

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Lincoln
National Health Service, United Kingdom; Sanandco Ltd

Active, not recruiting

Use of MonitorMe in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London
AstraZeneca

Withdrawn

GR Defect in Peripheral Blood Mononuclear Cells in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Edinburgh
Philips Healthcare

Completed

Physical Activity Enhancing Programme in COPD (PAEP)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Glasgow
NHS Research and Development

Completed

An Evaluation of Web Based Pulmonary Rehabilitation (webbasedPR)

Chronic Obstructive Pulmonary Disease

United Kingdom
Novartis Pharmaceuticals

Completed

Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD (INHALE)

Chronic Obstructive Pulmonary Disease

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
AstraZeneca; Newcastle University

Completed

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Chiesi Farmaceutici S.p.A.

Recruiting

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI) (TRIBE)

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London

Withdrawn

Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London
AstraZeneca

Completed

Effect of Symbicort ® on GR in Sputum in COPD

Chronic Obstructive Lung Disease

United Kingdom
National Services for Health Improvement Ltd
GlaxoSmithKline

Completed

Characterisation of People With COPD (CoCO)

Chronic Obstructive Pulmonary Disease

United Kingdom
Dr Ian B Wilkinson
University College London Hospitals; Imperial College London; Newcastle University and other collaborators

Recruiting

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations (OPACE)

Chronic Obstructive Pulmonary Disease

United Kingdom

Clinical Trials on Chronic Obstructive Airway Disease in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations